Therapeutics: Integrin β1 (CD29)

Musculoskeletal disease

INDICATION: Tissue damage; muscular dystrophy

Mouse studies suggest an agonist mAb

Read the full 119 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE